Hematologic Malignancy Clinical Trials

231 clinical trials for Hematologic Malignancy across international registries, including 67 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO) — RECRUITING · PHASE1
• Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies — RECRUITING · PHASE1
• Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment — RECRUITING
• Mosaic Trial for Stem Cell Transplant Recipients — RECRUITING · NA
• ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period — RECRUITING · NA
• CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma — RECRUITING · PHASE1
• Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment — RECRUITING · NA
• Implementation of an Oral Chemotherapy Adherence Intervention — RECRUITING · NA
• A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant — RECRUITING · PHASE2
• Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers — RECRUITING · NA
• CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation — RECRUITING · PHASE1
• Prospective Cohort With Hemopathy in Languedoc-Roussillon — RECRUITING
• Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy — RECRUITING
• Allergy Delabeling in Antibiotic Stewardship - Intervention — RECRUITING · PHASE4
• Response to Influenza Vaccination in Pediatric Oncology Patients — RECRUITING
• An Extension Study for Patients Previously Enrolled in Studies With Pelabresib — RECRUITING · PHASE3
• Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors. — RECRUITING · PHASE1
• Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy — RECRUITING · NA
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies — RECRUITING · PHASE1
• Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy — RECRUITING
• Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant — RECRUITING
• Global Cardio Oncology Registry — RECRUITING
• Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients — RECRUITING · PHASE2
• Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation — RECRUITING · NA
• Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy — RECRUITING · NA
• Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation — RECRUITING
• Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies — RECRUITING · PHASE2
• Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT — RECRUITING · PHASE3
• Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials — RECRUITING
• Long-Term Follow-up Study — RECRUITING
• Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies — RECRUITING · PHASE1
• Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI) — RECRUITING · PHASE2
• Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation — RECRUITING · PHASE2
• CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies — RECRUITING · PHASE1
• HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT — RECRUITING · PHASE1
• Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies — RECRUITING
• Diet and Cognitive Training in Hematologic Cancer Survivors — RECRUITING · NA
• Home Blood Transfusions — RECRUITING · NA
• Immune Profiling for Cancer Immunotherapy Response — RECRUITING
• BMT-CARE: Psychosocial Intervention for Transplant Caregivers — RECRUITING · NA
• Telerehabilitation in Hemato-oncological Survivors — RECRUITING · NA
• Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies — RECRUITING · PHASE1
• HEME Home Transfusion Program — RECRUITING · NA
• Early Assessment of Cardiac Function After Treatment With CAR-T Cells — RECRUITING
• A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies — RECRUITING
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer — RECRUITING
• Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial — RECRUITING · PHASE2
• T-cell Developmental Status in Patients With Malignant Hematological Tumors — RECRUITING

Refine this search